Cargando…
Intraperitoneal administration of fosfomycin, metronidazole, and granulocyte-macrophage colony-stimulating factor in patients undergoing appendectomy is safe: a phase II clinical trial
We aimed to investigate the safety of intraperitoneal administration of the combination of fosfomycin, metronidazole, and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing appendectomy. We conducted a prospective phase II clinical trial in 14 otherw...
Autores principales: | Fonnes, Siv, Holzknecht, Barbara Juliane, Arpi, Magnus, Rosenberg, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491470/ https://www.ncbi.nlm.nih.gov/pubmed/31040341 http://dx.doi.org/10.1038/s41598-019-43151-4 |
Ejemplares similares
-
Shorter Total Length of Stay After Intraperitoneal Fosfomycin, Metronidazole, and Molgramostim for Complicated Appendicitis: A Pivotal Quasi-Randomized Controlled Trial
por: Fonnes, Siv, et al.
Publicado: (2020) -
Nighttime Appendectomy is Safe and has Similar Outcomes as Daytime Appendectomy: A Study of 1198 Appendectomies
por: Mönttinen, T., et al.
Publicado: (2020) -
Effect of Co‐administration of Granulocyte Colony‐stimulating Factor on Interferon Therapy
por: Segawa, Kotaro, et al.
Publicado: (1991) -
Laparoscopic appendectomy in complicated appendicitis: Is it safe?
por: Mohamed, Ashraf A, et al.
Publicado: (2013) -
Case Report: The importance of examining colon and rectum in patients with appendiceal cancer
por: Reistrup, Hugin, et al.
Publicado: (2022)